Network 9 Bio Tech Pharma

What is Network 9? Watch this 1 minute video and find out.

Interact with nine or more professionals from your field of interest. Learn more about what they do, where they work, and how they got started - all at an event that's small enough to promote real conversations.

Cancellation

Attendance, Expectations, Courtesy, and Professionalism

If for any reason you realize you cannot attend, up to the day of the event, contact The Offices of Strengths and Vocation (located on the 3rd floor of the Ryan Learning Center) between 8:00 a.m. and 4:30 p.m., in person, by phone at 619-849-2446, or by e-mail osv@pointloma.edu. Note: The office closes at 4:30 p.m.

Signing up for this event constitutes your commitment to attend. The purpose of this event is to help you develop potential for long-term success by forging the right connections. A significant expense is made by OSV for all of our networking events. When individuals no-show, this impacts and is a discourtesy to hosts, planners, sponsors, and the other students. True emergencies, which are rare, with prompt contacts to explain, are understood. Changing your mind about attendance at the last minute does not constitute an emergency.

Register

Contact for Questions

Network with professionals from the following companies!

Genomics Institute of the Novartis Research Foundation (GNF)

David Jones, Research Scientist

Dr. David Jones currently works at Genomics Institute of the Novartis Research Foundation (GNF). Over the past 8 years his role at the institute has evolved into running the NMR group and the protein biophysical core. He is responsible for supporting all the NMR activities including: maintaining instruments, training users, providing small molecule structure elucidation service, protein/peptide structure determination, protein expression/ purification, isotope labelling, protein/small molecule binding, fragment-based screening, etc. The protein biophysical core supports biotherapeutic programs using 10 different biophysical/ analytical methods to characterize proteins (size, hydrophobicity, stability, etc.) and their binding interactions (affinity, stoichiometry, on/off rates). As a technology platform/ research area Dr. Jones develops methods that employ unnatural amino acids and leverage the unique properties they provide (reactivity, isotopes, etc.) to help drive group activities. Prior to GNF, Dr. Jones was an application scientist at Bruker Biospin where he was responsible for West Coast software and hardware support, instructing NMR users, and liquid chromatography-NMR (LC-NMR) applications.

Dr. Jones received his Ph.D. in Biochemistry from the University of Western Ontario, Canada using wideline deuterium NMR to study the structure/dynamics of glycolipids and transmembrane proteins in lipid bilayers. He started a post-doc in the Department of Chemistry at the University of Pennsylvania, Philadelphia using solid-state NMR to study the HIV-1 membrane protein Vpu lipid bilayers. During this time Dr. Jones developed methods to express and purify the toxic membrane protein and because all the NMR equipment was home-built he became very familiar with repairing/rebuilding NMR consoles and probes. After ~1.5 years his supervisor decided to relocate to the University of California, San Diego. Dr. Jones was asked to come and help setup the 400, 550, 700, and 750 MHz NMR machines. Unfortunately, the building was not ready when they arrived in San Diego and during the downtime he switched from solid-state to solution NMR and learned electrophysiology methods to examine the channel function of proteins reconstituted in lipid bilayers.

Accelerate-research.com

Jayashree Srinivasan, Manager and Senior Scientist

Dr. Jayashree Srinivasan received her M.Sc. in Chemistry and her Ph.D. in BioPhysical Chemistry at Wesleyan University. Dr. Srinivasan is an independent consultant who specializes in computational science for the pharmaceutical industry. Experiences include structure based drug design, virtual screening, QSAR, and data analysis. She has 17 years of experience as a computational chemist, working closely as a member of wet medical chemistry and biology teams.

GenoLogics Life Sciences Software

Bruce Windoffer, Technical Sales Executive

Bruce Windoffer’s career can be summed up as having sold, at one time or another, everything possibly related to science: reagents and supplies, lab furniture and design, high-end instrumentation, laboratory robotics, research services, and software. Clients have been mostly on the west coast of North America consisting of life science and chemistry labs in universities, pharmaceutical, biotechnology, and diagnostic companies, and hospital labs.

Mr. Windoffer received his Bachelor's degree in chemistry from Point Loma College - now Point Loma Nazarene University - in 1978. Starting his career as an environmental chemist at Truesdail Laboratories he then moved his office from the lab bench to the car working for Fisher Scientific - now Thermo Fisher - as an outside sales representative. Wanting a more technical role, he took a technical sales position with Beckman Instruments - now Beckman Coulter - selling their complete line of life sciences instrumentation including: liquid scintillation counters, laboratory robotics, HPLC, centrifugation products, and DNA analysis and sequencing instruments.

In 1993, Mr. Windoffer transitioned into selling software for the life sciences beginning with Molecular Simulations - now Accelrys - and then Spotfire - now TIBCO Spotfire until semi-retirement in 2011. Desiring to be involved in the emerging field of personalized medicine, he joined GenoLogics Life Sciences Software as Technical Sales Executive in 2012, where he remains. In this position he has been involved in projects related to bringing clinical genomics to medical practice at places such as St. Jude's Children's Hospital, Children's Hospital of Los Angeles, MD Anderson Cancer Center, and many more.

University of California, San Diego

Doug Zuill, Staff Research Associate

Doug Zuill is an alumnus of PLNU Biology and Chemistry. An education in microbiology and organic chemistry has allowed Mr. Zuill to concentrate his employment in the research of anti-infective therapies. For two years, he worked as a molecular biologist developing the novel antibiotic Tedizolid phosphate at the San Diego Biotech company Trius Therapeutics. Due to the immense success of Tedizolid in the treatment of bacterial infections, Trius was purchased in an $850 million acquisition. Following Trius’ closure, Mr. Zuill used his newfound expertise to create work as a drug resistance specialist. He was hired as a consultant at UCSD to aid labs that utilize bacterial proteins as anti-parasitic agents against human intestinal parasites. Additionally, Mr. Zuill has collaborated with Bayer Pharmaceuticals to assess the efficacy of Pore Forming Toxins against agricultural parasites. These experiences from the industry have also allowed him to teach Cell and Molecular Biology labs at PLNU. His current goals are to pursue a Ph.D. in microbiology and continue to research chemical therapies for human pathogens.